SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 17.88 |
| Enterprise Value ($M) | 32.83 |
| Book Value ($M) | 38.13 |
| Book Value / Share | 1.60 |
| Price / Book | 0.47 |
| NCAV ($M) | -11.45 |
| NCAV / Share | -0.48 |
| Price / NCAV | -1.56 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.42 |
| Return on Assets (ROA) | -0.30 |
| Return on Equity (ROE) | -0.49 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.33 |
| Current Ratio | 1.47 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 42.23 |
| Assets | 91.81 |
| Liabilities | 53.68 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Karkus Ted William | 20.30 | 2.79 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 2,022 | 76,809 | 2.63 | |
| 13,572 | 89,366 | 15.19 | |
| 9,902 | 103,100 | 9.60 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PMN – ProMIS Neurosciences, Inc. | PRFX – PainReform Ltd. |
| PROK – ProKidney Corp. | PRQR – ProQR Therapeutics N.V. |
| PRTG – Portage Biotech Inc. |
Financial data and stock pages provided by
Fintel.io